HYPERION DEFI INC (HYPD)
NASDAQHealth CareAsset Management - CryptocurrencySnapshot 2026-11-05
$2.56-16.61%
Close 2026-11-05 · 1-day change
NASDAQHealth CareAsset Management - CryptocurrencySnapshot 2026-11-05
QuarterlyIQ Insights · HYPD
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.
Stated in 2 of 2 supplied quarters. Management reported: “In total, Adjusted Gross Profit (1) increased +20% quarter-over-quarter to $1.15 million in Q2’26 from $960 thousand in Q1’26.” “And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 3 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 53% of the time over the next year (vs 42% for the rest of the cohort, n=10089).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.”
“· We anticipate $5M-$7M Adjusted Gross Profit (1) in 2026, ~5x our 2025 FY results, which represents a +$1M increase in range from our Q4’25 earnings release.”
KNTQ staking yields have recently exceeded 7% annualized, and we have accrued over 40,000 additional KNTQ tokens in 2026.
Stated in 2 of 2 supplied quarters. Management reported: “KNTQ staking yields have recently exceeded 7% annualized, and we have accrued over 40,000 additional KNTQ tokens in 2026.” “We are liquid-staking our KNTQ with Kinetiq and earning more KNTQ tokens over time.”
“KNTQ staking yields have recently exceeded 7% annualized, and we have accrued over 40,000 additional KNTQ tokens in 2026.”
“We anticipate Operating Expenses Excluding Stock-Based Compensation (5) to further decline below a quarterly run-rate of $3.0 million beginning in Q2’26 driven by the exit of legacy biotech operation…”
And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.
Stated in 2 of 2 supplied quarters. Management reported: “For the past two quarters, 40%-50% of our Adjusted Gross Profit (1) was denominated in cash, cash equivalents, and stablecoins (16) .” “And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.”
“And, we anticipate our Adjusted Net Operating Cash Flow (18) to flip positive by the end of 2026.”
“In light of our continued momentum, today we are increasing our guidance for our DeFi operating segments for full-year 2026, and we continue to anticipate achieving break-even cash flows by the end o…”
We believe the strength of our strategic positioning was demonstrated within weeks via our two new HAUS agreements deploying 1 million HYPE tokens as detailed below.
Stated in 2 of 2 supplied quarters. Management reported: “We believe the strength of our strategic positioning was demonstrated within weeks via our two new HAUS agreements deploying 1 million HYPE tokens as detailed below.” “The early metrics are positive, with over 40,000 unique users signed up to access Skew’s private beta as of August 10, 2026.”
“We believe the strength of our strategic positioning was demonstrated within weeks via our two new HAUS agreements deploying 1 million HYPE tokens as detailed below.”
“4 o In Q1’26, we entered into a HAUS agreement with Silhouette.”
Deploy HYPE tokens strategically across staking, validator commissions, yield enhancement, and DeFi monetization to maximize returns.
Over the trailing year it converted 1.84x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
36 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Health Care names rated volatile grew net income 45% of the time over the next year (vs 45% for the rest of the cohort, n=10076).
Not investment advice. As of 2026-11-05.